Log in with your email address username.

×

Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

A budding surprise from the joint

- Featured Image

Reactivation of dormant infections is increasingly recognised with immunosuppression for rheumatic diseases. Septic arthritis from dimorphic fungi is exceedingly rare in non-endemic settings. We describe the first Australian case of Histoplasma capsulatum septic arthritis in a man of Laotian descent who was receiving treatment for seropositive rheumatoid arthritis.

Clinical record

A 78-year-old man of Laotian descent but resident in Australia for many years was referred in October 2010 with bilateral wrist extensor tenosynovitis, and a diagnosis of seropositive rheumatoid arthritis was made (cyclic citrullinated peptide antibody level, > 200 U/mL [reference interval, < 5 U/mL]; rheumatoid-factor negative). Although oral methotrexate initially improved disease control, he later had progressive disease involving his knees and ankles. Prednisone (5–15 mg daily) and leflunomide (10 mg daily) were added without much improvement, and he was considered for further immune modulation therapy. The patient’s background included tuberculous cervical lymphadenitis in 2009 (positive result of culture for Mycobacterium tuberculosis), treated with 12 months of standard quadruple therapy.

In March…

email